iBio Inc. Annual report pursuant to Section 13 and 15(d)

Name:	ibio_CommitmentsAndContingenciesLineItems
Namespace Prefix:	ibio_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

The amount of initial license fee paid by the company during the reporting period.

No definition available.

Name:	ibio_InitialLicenseFee
Namespace Prefix:	ibio_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Long term purchase commitment expired date.

No definition available.

Name:	ibio_LongTermPurchaseCommitmentExpireDate
Namespace Prefix:	ibio_
Data Type:	xbrli:dateItemType
Balance Type:	na
Period Type:	duration

Research services agreements value fulfilling commitment during the reporting period.

No definition available.

Name:	ibio_ResearchServicesAgreementsValueFulfillingCommitement
Namespace Prefix:	ibio_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Termination of research services agreements value fulfilling commitment during the reporting period.

No definition available.

Name:	ibio_TerminationOfResearchServicesAgreement
Namespace Prefix:	ibio_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.

No definition available.

Name:	us-gaap_ContractualObligation
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

Amount of contractual obligation due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.

No definition available.

Name:	us-gaap_ContractualObligationDueInNextTwelveMonths
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

Amount of contractual obligation due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.

No definition available.

Name:	us-gaap_ContractualObligationDueInSecondYear
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

Costs incurred and are directly related to generating license revenue. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark.

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.2(e))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Name:	us-gaap_LicenseCosts
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 730

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 985

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

Name:	us-gaap_ResearchAndDevelopmentExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

The amount the entity has committed to make for future royalty guarantees.

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 928

-SubTopic 440

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6473578&loc=d3e63223-108013

Name:	us-gaap_RoyaltyGuaranteesCommitmentsAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

Name:	us-gaap_CounterpartyNameAxis=ibio_FraunhoferMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_EligibleItemOrGroupForFairValueOptionAxis=us-gaap_CommitmentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_RangeAxis=us-gaap_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: